{"DataElement":{"publicId":"13345476","version":"1","preferredName":"Tumor Identifier Domain Neoplasm ICD-O-3 Behavior Code","preferredDefinition":"The code that identifies the behavior of a neoplasm as per ICD-O-3.","longName":"TUMORBCD","context":"PMI","contextVersion":"1","DataElementConcept":{"publicId":"13345475","version":"1","preferredName":"Tumor Identifier Domain Neoplasm ICD-O-3 Behavior Code","preferredDefinition":"A domain that represents the data that uniquely identifies tumors.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The code for the behavior of the tumor being reported using ICD-O-3.","longName":"6607938v1.00:13345474v1.00","context":"PMI","contextVersion":"1","ObjectClass":{"publicId":"6607938","version":"1","preferredName":"Tumor Identifier Domain","preferredDefinition":"A domain that represents the data that uniquely identifies tumors.","longName":"C106577","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Identifier Domain","conceptCode":"C106577","definition":"A domain that represents the data that uniquely identifies tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1D6F05-C099-2E3D-E053-F662850A5D84","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13345474","version":"1","preferredName":"Neoplasm ICD-O-3 Behavior Code","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The code for the behavior of the tumor being reported using ICD-O-3.","longName":"C3262:C160910","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ICD-O-3 Behavior Code","conceptCode":"C160910","definition":"The code for the behavior of the tumor being reported using ICD-O-3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F917CBEE-54CF-723D-E053-731AD00A3B4B","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PMI CDISC Harmonization","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F917CBEE-54D0-723D-E053-731AD00A3B4B","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13345473","version":"1","preferredName":"Neoplasm ICD-O-3 Behavior Code","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The code for the behavior of the tumor being reported using ICD-O-3._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"13345473v1.00","context":"PMI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":null,"ValueMeaning":{"publicId":"2938141","version":"1","preferredName":"Benign Neoplasm","longName":"2938141v1.00","preferredDefinition":"A neoplasm characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Neoplasm","conceptCode":"C3677","definition":"A neoplasm characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7289D43E-7E19-ACC7-E040-BB89AD431D77","latestVersionIndicator":"Yes","beginDate":"2009-09-01","endDate":null,"createdBy":"UMLLOADER_TCGA","dateCreated":"2009-09-01","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F917BD33-FE3C-705E-E053-731AD00A84A3","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"1","valueDescription":null,"ValueMeaning":{"publicId":"6660967","version":"1","preferredName":"Neoplasm, Uncertain Whether Benign or Malignant","longName":"6660967v1.00","preferredDefinition":"A neoplasm which, on morphologic grounds, can not be classified with certainty as benign or malignant.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm, Uncertain Whether Benign or Malignant","conceptCode":"C65157","definition":"A neoplasm which, on morphologic grounds, can not be classified with certainty as benign or malignant.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830EC13A-C1C0-147E-E053-F662850AE841","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TSESU","dateCreated":"2019-03-01","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F917BD33-FE3D-705E-E053-731AD00A84A3","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"2","valueDescription":null,"ValueMeaning":{"publicId":"2935534","version":"1","preferredName":"Carcinoma In Situ","longName":"2935534v1.00","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4DE-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":"Updated definition with current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F917BD33-FE3E-705E-E053-731AD00A84A3","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"3","valueDescription":null,"ValueMeaning":{"publicId":"3211557","version":"1","preferredName":"Primary Malignant Neoplasm","longName":"3211557v1.00","preferredDefinition":"A malignant tumor at the original site of growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Malignant Neoplasm","conceptCode":"C84509","definition":"A malignant tumor at the original site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F5324E1-CB2A-4BBA-E040-BB89AD4346F8","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F917BD33-FE3F-705E-E053-731AD00A84A3","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"6","valueDescription":null,"ValueMeaning":{"publicId":"3211553","version":"1","preferredName":"Metastatic Malignant Neoplasm","longName":"3211553v1.00","preferredDefinition":"A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm","conceptCode":"C36263","definition":"A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F5324E1-CA6D-4BBA-E040-BB89AD4346F8","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F917BD33-FE40-705E-E053-731AD00A84A3","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"9","valueDescription":null,"ValueMeaning":{"publicId":"6832961","version":"1","preferredName":"Malignant Neoplasm, Uncertain Whether Primary or Metastatic","longName":"6832961v1.00","preferredDefinition":"A malignant neoplasm in which the examined tissue can not be determined with certainty if it represents the primary site of tumor growth or tumor spread from another anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm, Uncertain Whether Primary or Metastatic","conceptCode":"C65153","definition":"A malignant neoplasm in which the examined tissue can not be determined with certainty if it represents the primary site of tumor growth or tumor spread from another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9C13A5-92B2-690F-E053-F662850AD8D9","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-26","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F917BD33-FE41-705E-E053-731AD00A84A3","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13345472","version":"1","preferredName":"Neoplasm ICD-O-3 Behavior Code Code","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The code for the behavior of the tumor being reported using ICD-O-3._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"13345472v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"ICD-O-3 Behavior Code","conceptCode":"C160910","definition":"The code for the behavior of the tumor being reported using ICD-O-3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F917B525-BF47-6F15-E053-731AD00AE6C8","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PMI CDISC Harmonization","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F917B525-BF48-6F15-E053-731AD00AE6C8","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7765162","version":"1","longName":"PMI CDISC Harmonization","context":"PMI","ClassificationSchemeItems":[{"publicId":"13470911","version":"1","longName":"PMI CDISC EC Template v2.0","context":"PMI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Tumor Behavior Code","url":null,"context":"PMI"},{"name":"PMI - 1","type":"Alternate Question Text","description":"Tumor behavior code","url":null,"context":"PMI"}],"origin":"PMI CDISC Harmonization","workflowStatus":"DRAFT NEW","registrationStatus":"Qualified","id":"F917D471-0ED5-734B-E053-731AD00A613B","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-11","modifiedBy":"GDEEN","dateModified":"2023-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}